Hongxing Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hongxing Huang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Zhihai Zhang
The Third Affiliated Hospital Of Guangzhou University of Chinese Medicine, Guangzhou, China
2 shared publications Zhiwen Liu
The Third Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China
2 shared publicationsZijing Peng
The Third Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China
2 shared publicationsBangning Gu
The Third Clinical College of Guangzhou University of Chinese Medicine
1 shared publicationFangming Yao
The Third Clinical College of Guangzhou University of Chinese Medicine
1 shared publication- Hewei Wei
The Third Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 29 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1757121
Distribution of lower limb muscles may be associated with the progression of knee osteoarthritis and sarcopenia: a cross-sectional study
Objective: This study aimed to delineate and segment the distribution of lower limb muscles based on full-length anteroposterior digital radiography (DR) of patients with varus knee osteoarthritis (vKOA), to quantitatively assess regional muscle abundance, and to explore its associations with vKOA progression and the risk of sarcopenia (SP). Methods: A total of 79 vKOA patients (124 lower limbs) admitted to the Joint Center of the Third Affiliated Hospital of Guangzhou University of Chinese Medicine between January 2023 and January 2024 were enrolled according to predefined inclusion and exclusion criteria. Inclusion criteria were: knee pain within the past month, age ≥ 50 years, morning stiffness < 30 min, and radiographic findings of joint space narrowing, subchondral sclerosis and/or cystic changes, and osteophyte formation. Exclusion criteria were: valgus KOA or other forms of arthritis, concomitant diseases affecting lower limb function, lower limb deformities of other etiologies, and inability to comply with data collection. Demographic and clinical information, including sex, age, height, weight, body mass index (BMI), diabetes, and hypertension, were collected. From DR images, muscle area indices were extracted from five anatomical sites: femoral lateral muscle, femoral medial muscle, tibial medial muscle, crural interosseous muscle, and lateral fibular muscle. Varus KOA related parameters, including hip–knee–ankle angle (HKA), joint line convergence angle (JLCA), medial joint space width (MJSW), and lateral joint space width (LJSW), were recorded. Appendicular skeletal muscle mass index (ASMI) was obtained using dual-energy X-ray absorptiometry (DXA). Patients were categorized into SP with vKOA (SP-vKOA) and vKOA groups according to the Asian Working Group for Sarcopenia criteria, and into mild vKOA (Kellgren–Lawrence grade 1–2) and severe vKOA (grade 3–4) groups. Intergroup analyses were performed using the rank-sum test, independent-sample t -test, and chi-square test. Binary logistic regression was applied to assess associations between muscle area indices and vKOA severity or SP risk, while linear regression was used to evaluate correlations between muscle distribution ratios and varus deformity. Receiver operating characteristic (ROC) curves were constructed to evaluate diagnostic performance. Results: Binary logistic regression indicated that the tibial medial muscle area index (TMMAI) [odds ratio ( OR ) = 0.054, 95% confidence interval ( CI ): 0.010–0.302] and weighted average density value (WADV) ( OR = 0.996, 95% CI : 0.993–0.998) were significantly associated with SP occurrence. The combined ROC curve yielded an area under the curve ( AUC ) of 0.852 (95% CI : 0.727–0.881, P < 0.001), with a maximum Youden index of 0.594, optimal cutoff of 0.411, sensitivity of 79.17%, and specificity of 80.26%. Age ( OR = 1.081, 95% CI : 1.014–1.152, P < 0.05) and the femoral lateral muscle area index (FLMAI) ( OR = 0.120, 95% CI : 0.021–0.697, P < 0.05) were significantly associated with vKOA progression. The combined ROC curve showed an AUC of 0.789 (95% CI : 0.709–0.869, P < 0.001), maximum Youden index of 0.479, optimal cutoff of 0.533, sensitivity of 76.47%, and specificity of 71.43%. The ratio of femoral medial muscle area index to femoral lateral muscle area index (FMMAI/FLMAI) correlated with varus deformity, being significantly negatively associated with HKA ( t = –2.64, P < 0.05), significantly positively associated with JLCA ( t = 4.477, P < 0.05), and significantly negatively associated with MJSW ( t = –4.278, P < 0.05). Conclusion: In patients with vKOA, atrophy of the femoral lateral muscle and imbalance in femoral medial-to-lateral muscle distribution may contribute to vKOA progression, while atrophy of the tibial medial muscle may be linked to the development of SP. Targeted rehabilitation strategies focusing on specific muscle groups in vKOA patients may help alleviate disease progression and reduce the incidence of SP.
- 29 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1757121
Open AccessDistribution of lower limb muscles may be associated with the progression of knee osteoarthritis and sarcopenia: a cross-sectional study
Objective: This study aimed to delineate and segment the distribution of lower limb muscles based on full-length anteroposterior digital radiography (DR) of patients with varus knee osteoarthritis (vKOA), to quantitatively assess regional muscle abundance, and to explore its associations with vKOA progression and the risk of sarcopenia (SP). Methods: A total of 79 vKOA patients (124 lower limbs) admitted to the Joint Center of the Third Affiliated Hospital of Guangzhou University of Chinese Medicine between January 2023 and January 2024 were enrolled according to predefined inclusion and exclusion criteria. Inclusion criteria were: knee pain within the past month, age ≥ 50 years, morning stiffness < 30 min, and radiographic findings of joint space narrowing, subchondral sclerosis and/or cystic changes, and osteophyte formation. Exclusion criteria were: valgus KOA or other forms of arthritis, concomitant diseases affecting lower limb function, lower limb deformities of other etiologies, and inability to comply with data collection. Demographic and clinical information, including sex, age, height, weight, body mass index (BMI), diabetes, and hypertension, were collected. From DR images, muscle area indices were extracted from five anatomical sites: femoral lateral muscle, femoral medial muscle, tibial medial muscle, crural interosseous muscle, and lateral fibular muscle. Varus KOA related parameters, including hip–knee–ankle angle (HKA), joint line convergence angle (JLCA), medial joint space width (MJSW), and lateral joint space width (LJSW), were recorded. Appendicular skeletal muscle mass index (ASMI) was obtained using dual-energy X-ray absorptiometry (DXA). Patients were categorized into SP with vKOA (SP-vKOA) and vKOA groups according to the Asian Working Group for Sarcopenia criteria, and into mild vKOA (Kellgren–Lawrence grade 1–2) and severe vKOA (grade 3–4) groups. Intergroup analyses were performed using the rank-sum test, independent-sample t -test, and chi-square test. Binary logistic regression was applied to assess associations between muscle area indices and vKOA severity or SP risk, while linear regression was used to evaluate correlations between muscle distribution ratios and varus deformity. Receiver operating characteristic (ROC) curves were constructed to evaluate diagnostic performance. Results: Binary logistic regression indicated that the tibial medial muscle area index (TMMAI) [odds ratio ( OR ) = 0.054, 95% confidence interval ( CI ): 0.010–0.302] and weighted average density value (WADV) ( OR = 0.996, 95% CI : 0.993–0.998) were significantly associated with SP occurrence. The combined ROC curve yielded an area under the curve ( AUC ) of 0.852 (95% CI : 0.727–0.881, P < 0.001), with a maximum Youden index of 0.594, optimal cutoff of 0.411, sensitivity of 79.17%, and specificity of 80.26%. Age ( OR = 1.081, 95% CI : 1.014–1.152, P < 0.05) and the femoral lateral muscle area index (FLMAI) ( OR = 0.120, 95% CI : 0.021–0.697, P < 0.05) were significantly associated with vKOA progression. The combined ROC curve showed an AUC of 0.789 (95% CI : 0.709–0.869, P < 0.001), maximum Youden index of 0.479, optimal cutoff of 0.533, sensitivity of 76.47%, and specificity of 71.43%. The ratio of femoral medial muscle area index to femoral lateral muscle area index (FMMAI/FLMAI) correlated with varus deformity, being significantly negatively associated with HKA ( t = –2.64, P < 0.05), significantly positively associated with JLCA ( t = 4.477, P < 0.05), and significantly negatively associated with MJSW ( t = –4.278, P < 0.05). Conclusion: In patients with vKOA, atrophy of the femoral lateral muscle and imbalance in femoral medial-to-lateral muscle distribution may contribute to vKOA progression, while atrophy of the tibial medial muscle may be linked to the development of SP. Targeted rehabilitation strategies focusing on specific muscle groups in vKOA patients may help alleviate disease progression and reduce the incidence of SP.
- Open Access
- 10 January 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1467559
The association between dietary omega-3 intake and osteoporosis: a NHANES cross-sectional study
Background: Recent research suggests that omega-3 fatty acids may play a role in bone metabolism through their influence on bone mineral density (BMD) and the regulation of bone turnover markers. However, epidemiological evidence linking omega-3 intake to the risk of developing osteoporosis is still emerging and remains inconclusive. This study aims to clarify the role of dietary omega-3 fatty acids in the prevention of osteoporosis.Methods: We analyzed data from 8,889 participants categorized into normal, osteopenia, and osteoporosis groups based on their BMD scores from the National Health and Nutrition Examination Survey (NHANES). We measured dietary omega-3 intake using two 24-h dietary recall interviews. Dietary omega-3 intake was quantified and divided into quartiles. Multivariate logistic regression and subgroup analysis were used to explore the correlation between dietary omega-3 intake and osteoporosis. The dose–response relationship between the two was analyzed with a restricted cubic spline (RCS).Results: Higher dietary intake of omega-3 fatty acids was inversely associated with the risk of osteoporosis. Participants in the highest quartile of omega-3 intake had a significantly lower risk (OR = 0.71, 95% CI: 0.53–0.93) compared to those in the lowest quartile, with a consistent trend across all adjusted models (p for trend p for nonlinear = 0.366).Conclusion: This study demonstrates a significant inverse relationship between dietary omega-3 fatty acid intake and osteoporosis risk, suggesting omega-3 s play a crucial role in bone health. However, further longitudinal studies are needed to confirm these findings and refine dietary recommendations for osteoporosis prevention.
- 10 January 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1467559
Open AccessThe association between dietary omega-3 intake and osteoporosis: a NHANES cross-sectional study
Background: Recent research suggests that omega-3 fatty acids may play a role in bone metabolism through their influence on bone mineral density (BMD) and the regulation of bone turnover markers. However, epidemiological evidence linking omega-3 intake to the risk of developing osteoporosis is still emerging and remains inconclusive. This study aims to clarify the role of dietary omega-3 fatty acids in the prevention of osteoporosis.Methods: We analyzed data from 8,889 participants categorized into normal, osteopenia, and osteoporosis groups based on their BMD scores from the National Health and Nutrition Examination Survey (NHANES). We measured dietary omega-3 intake using two 24-h dietary recall interviews. Dietary omega-3 intake was quantified and divided into quartiles. Multivariate logistic regression and subgroup analysis were used to explore the correlation between dietary omega-3 intake and osteoporosis. The dose–response relationship between the two was analyzed with a restricted cubic spline (RCS).Results: Higher dietary intake of omega-3 fatty acids was inversely associated with the risk of osteoporosis. Participants in the highest quartile of omega-3 intake had a significantly lower risk (OR = 0.71, 95% CI: 0.53–0.93) compared to those in the lowest quartile, with a consistent trend across all adjusted models (p for trend p for nonlinear = 0.366).Conclusion: This study demonstrates a significant inverse relationship between dietary omega-3 fatty acid intake and osteoporosis risk, suggesting omega-3 s play a crucial role in bone health. However, further longitudinal studies are needed to confirm these findings and refine dietary recommendations for osteoporosis prevention.
- Open Access
- 9 November 2024
- Published by Springer Nature in Hereditas
- Vol. 161 (1) , 1-11
Serum vitamin C levels and risk of osteoporosis: results from a cross-sectional study and Mendelian randomization analysis
Background: The role of vitamin C as an antioxidant in guarding against osteoporosis in adults is still debated. This research employs both a cross-sectional study and a two-sample bidirectional Mendelian randomization (MR) analysis to explore how serum vitamin C levels correlate with the incidence of osteoporosis among adults. Methods: In this study, we utilized data from the National Health and Nutrition Examination Survey (NHANES) database for the years 2003–2006, and 2017–2018 to conduct both a cross-sectional analysis and MR to investigate the relationship between serum vitamin C levels and the risk of osteoporosis in adults. We adjusted our analyses for essential demographic and lifestyle variables, and applied logistic regression techniques. Genetic determinants of vitamin C levels were analyzed through MR, using methods like inverse-variance weighted (IVW) and MR-Egger to assess causality. Statistical computations were carried out in R, incorporating visual tools such as restricted cubic spline curves (RCS) and forest plots to clarify the dose–response dynamics and variations across different subgroups. This study was approved by the NCHS Ethics Review Board, and informed consent was obtained from all participants. Results: In our investigation, we analyzed data from 3,940 participants, among whom 291 were diagnosed with osteoporosis. The logistic regression analysis of serum vitamin C quartiles did not indicate a significant trend. The most adjusted model showed a slight, albeit inconsistent, protective effect in the highest quartile (OR = 0.68, 95% CI: 0.47–0.99, P = 0.22). Mendelian randomization, employing methods such as IVW, reinforced the absence of a significant causal relationship between serum vitamin C levels and osteoporosis risk (IVW OR = 1.000, 95% CI: 0.999–1.001, P = 0.601).Subgroup analyses, visualized through forest plots and restricted cubic spline (RCS) curves, supported the primary findings, showing no significant effects or interactions between vitamin C levels and osteoporosis risk across different demographic and lifestyle subgroups. The RCS analysis particularly highlighted a lack of significant non-linear relationships between serum vitamin C concentration and the odds of osteoporosis (P for nonlinear = 0.840). Conclusions: The cross-sectional study revealed that higher serum vitamin C levels do not consistently correlate with a reduced risk of osteoporosis. Meanwhile, the Mendelian randomization analysis confirmed that there is no genetic evidence to suggest a causal relationship between vitamin C levels and osteoporosis risk. Recent research highlights the polygenic nature of osteoporosis, with genetic predispositions playing a significant role in disease risk. The relationship between serum vitamin C and osteoporosis requires further research. This suggests the need for further investigation into the connection between vitamin C and bone health.
- 9 November 2024
- Published by Springer Nature in Hereditas
- Vol. 161 (1) , 1-11
Open AccessSerum vitamin C levels and risk of osteoporosis: results from a cross-sectional study and Mendelian randomization analysis
Background: The role of vitamin C as an antioxidant in guarding against osteoporosis in adults is still debated. This research employs both a cross-sectional study and a two-sample bidirectional Mendelian randomization (MR) analysis to explore how serum vitamin C levels correlate with the incidence of osteoporosis among adults. Methods: In this study, we utilized data from the National Health and Nutrition Examination Survey (NHANES) database for the years 2003–2006, and 2017–2018 to conduct both a cross-sectional analysis and MR to investigate the relationship between serum vitamin C levels and the risk of osteoporosis in adults. We adjusted our analyses for essential demographic and lifestyle variables, and applied logistic regression techniques. Genetic determinants of vitamin C levels were analyzed through MR, using methods like inverse-variance weighted (IVW) and MR-Egger to assess causality. Statistical computations were carried out in R, incorporating visual tools such as restricted cubic spline curves (RCS) and forest plots to clarify the dose–response dynamics and variations across different subgroups. This study was approved by the NCHS Ethics Review Board, and informed consent was obtained from all participants. Results: In our investigation, we analyzed data from 3,940 participants, among whom 291 were diagnosed with osteoporosis. The logistic regression analysis of serum vitamin C quartiles did not indicate a significant trend. The most adjusted model showed a slight, albeit inconsistent, protective effect in the highest quartile (OR = 0.68, 95% CI: 0.47–0.99, P = 0.22). Mendelian randomization, employing methods such as IVW, reinforced the absence of a significant causal relationship between serum vitamin C levels and osteoporosis risk (IVW OR = 1.000, 95% CI: 0.999–1.001, P = 0.601).Subgroup analyses, visualized through forest plots and restricted cubic spline (RCS) curves, supported the primary findings, showing no significant effects or interactions between vitamin C levels and osteoporosis risk across different demographic and lifestyle subgroups. The RCS analysis particularly highlighted a lack of significant non-linear relationships between serum vitamin C concentration and the odds of osteoporosis (P for nonlinear = 0.840). Conclusions: The cross-sectional study revealed that higher serum vitamin C levels do not consistently correlate with a reduced risk of osteoporosis. Meanwhile, the Mendelian randomization analysis confirmed that there is no genetic evidence to suggest a causal relationship between vitamin C levels and osteoporosis risk. Recent research highlights the polygenic nature of osteoporosis, with genetic predispositions playing a significant role in disease risk. The relationship between serum vitamin C and osteoporosis requires further research. This suggests the need for further investigation into the connection between vitamin C and bone health.
- Open Access
- 22 June 2024
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 25 (1) , 1-9
Association between dietary folate intake and the risk of osteoporosis in adults: a cross-sectional study
Background: Increased intake of specific vitamins has been linked to a decreased prevalence of osteoporosis. However, the association between dietary folate intake and the risk of osteoporosis in the general population remains incompletely understood. Therefore, we aimed to determine the association between dietary folate intake and the risk of osteoporosis in the general population of the USA. Methods: In this cross-sectional study, data from the National Health and Nutrition Examination Survey (2017–2020) were collected. Osteoporosis was considered to be indicated by a bone mineral density greater than 2.5 standard deviations below the mean of the young adult reference group. Dietary folate intake was measured by a 24-hour dietary recall. Multivariate logistic regression models and restricted cubic spline models were used. Results: The study included 2297 participants (mean age: 63.69 ± 0.35 years), 49.92% of whom were female. In the general population, increased dietary folate intake was directly associated with a decreased risk of osteoporosis (P for trend = 0.005). In the age > 60 years and female subgroups, folate intake was inversely associated with the risk of osteoporosis (P for trend < 0.001). The dose‒response curve suggested that this association was nonlinear (P for nonlinearity = 0.015). Conclusions: Our cross-sectional study provides initial insights into the inverse association between dietary folate intake and the risk of osteoporosis in the general U.S. population. Further research is needed to confirm these associations.
- 22 June 2024
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 25 (1) , 1-9
Open AccessAssociation between dietary folate intake and the risk of osteoporosis in adults: a cross-sectional study
Background: Increased intake of specific vitamins has been linked to a decreased prevalence of osteoporosis. However, the association between dietary folate intake and the risk of osteoporosis in the general population remains incompletely understood. Therefore, we aimed to determine the association between dietary folate intake and the risk of osteoporosis in the general population of the USA. Methods: In this cross-sectional study, data from the National Health and Nutrition Examination Survey (2017–2020) were collected. Osteoporosis was considered to be indicated by a bone mineral density greater than 2.5 standard deviations below the mean of the young adult reference group. Dietary folate intake was measured by a 24-hour dietary recall. Multivariate logistic regression models and restricted cubic spline models were used. Results: The study included 2297 participants (mean age: 63.69 ± 0.35 years), 49.92% of whom were female. In the general population, increased dietary folate intake was directly associated with a decreased risk of osteoporosis (P for trend = 0.005). In the age > 60 years and female subgroups, folate intake was inversely associated with the risk of osteoporosis (P for trend < 0.001). The dose‒response curve suggested that this association was nonlinear (P for nonlinearity = 0.015). Conclusions: Our cross-sectional study provides initial insights into the inverse association between dietary folate intake and the risk of osteoporosis in the general U.S. population. Further research is needed to confirm these associations.
- Open Access
- 31 May 2019
- Published by Springer Nature in Journal of Biological Engineering
- Vol. 13 (1) , 50
Expression profile analysis of long non-coding RNA in skeletal muscle of osteoporosis by microarray and bioinformatics
Osteoporosis (OP) is a condition featured by bone mass loss and bone tissue microarchitectural alterations due to impaired tissue homeostasis favoring excessive bone resorption versus deposition. The trigger of such an impairment and the downstream molecular pathways involved are yet to be clarified. Long non-coding RNA (lncRNA) plays a role in gene transcription, protein expression and epigenetic regulation; and altered expression results in immune or metabolism related desease development. To determine whether lncRNAs are involved in osteoporosis, we analyzed the expression profile of lncRNAs and mRNAs in osteoporosis. Three pairs of osteoporosis patients (OP group) and healthy people controls (NC group) were screened by microarray. Quantitative polymerase chain reaction (qRT-PCR) was performed to confirm dysregulated lncRNA expressions in 5 pairs of OP and NC group tissues samples. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to construct the lncRNA-mRNA co-expression network. Through co-expression analysis, differently expressed transcripts were divided into modules, and lncRNAs were functionally annotated. We further analyzed the clinical significance of crucial lncRNAs from modules in public data. Finally, the expression of five lncRNAs, CUST_44695_PI430048170-GeneSymbol:CTA-384D8.35;CUST_39447_PI430048170,CUST_73298_PI430048170,CUST_108340_PI430048170,CUST_118927_PI430048170,this four lncRNAs have not been annotation genes and have not found GeneSymbols, and by quantitative RT-PCR, which may be associated with osteoporosis patients’ overall survival. Analysis of this study revealed that dysregulated lncRNAs and mRNAs in osteoporosis patients and health people controls could affect the immune or metabolism system and musculoskeletal cell differentiation. The biological functions of those lncRNAs need to be further validated.
- 31 May 2019
- Published by Springer Nature in Journal of Biological Engineering
- Vol. 13 (1) , 50
Open AccessExpression profile analysis of long non-coding RNA in skeletal muscle of osteoporosis by microarray and bioinformatics
Osteoporosis (OP) is a condition featured by bone mass loss and bone tissue microarchitectural alterations due to impaired tissue homeostasis favoring excessive bone resorption versus deposition. The trigger of such an impairment and the downstream molecular pathways involved are yet to be clarified. Long non-coding RNA (lncRNA) plays a role in gene transcription, protein expression and epigenetic regulation; and altered expression results in immune or metabolism related desease development. To determine whether lncRNAs are involved in osteoporosis, we analyzed the expression profile of lncRNAs and mRNAs in osteoporosis. Three pairs of osteoporosis patients (OP group) and healthy people controls (NC group) were screened by microarray. Quantitative polymerase chain reaction (qRT-PCR) was performed to confirm dysregulated lncRNA expressions in 5 pairs of OP and NC group tissues samples. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to construct the lncRNA-mRNA co-expression network. Through co-expression analysis, differently expressed transcripts were divided into modules, and lncRNAs were functionally annotated. We further analyzed the clinical significance of crucial lncRNAs from modules in public data. Finally, the expression of five lncRNAs, CUST_44695_PI430048170-GeneSymbol:CTA-384D8.35;CUST_39447_PI430048170,CUST_73298_PI430048170,CUST_108340_PI430048170,CUST_118927_PI430048170,this four lncRNAs have not been annotation genes and have not found GeneSymbols, and by quantitative RT-PCR, which may be associated with osteoporosis patients’ overall survival. Analysis of this study revealed that dysregulated lncRNAs and mRNAs in osteoporosis patients and health people controls could affect the immune or metabolism system and musculoskeletal cell differentiation. The biological functions of those lncRNAs need to be further validated.